Opportunity
DIBBS #SPE2DP-26-T-3787
DLA Solicitation for Cefazolin Sodium Injection, USP (1g Vials, 25's)
Posted
June 12, 2026
Respond By
June 17, 2026
Identifier
SPE2DP-26-T-3787
NAICS
325412
This opportunity from the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain seeks offers for Cefazolin Sodium Injection, USP. - Government Buyer: - Defense Logistics Agency (DLA) - DLA Troop Support Medical Supply Chain - Pharmaceutical Field Support Activity - OEMs and Vendors: - Hikma Pharmaceuticals USA Inc. - WG Critical Care, LLC - Additional approved source (CAGE 1DQP2) - Products Requested: - Cefazolin Sodium Injection, USP - NSN 6505-01-480-2501 - 1 gram vials, 25 units per package - Part numbers: NDC00143-9924-90, NDC44567-0707-25, NDC63323-0237-10 - Total quantity: 4 units - Notable Requirements: - Delivery required within 20 days, FOB destination to Fort Bragg, NC - Compliance with Berry Amendment and Buy American Act - Prohibition on covered defense telecommunications equipment - 24-month shelf life - Packaging per MIL-STD-2073-1E and Medical Marking Standard No. 1 - FDA regulated drug - Multiple approved manufacturers and part numbers
Description
CEFAZOLIN INJECTION (QTY: 4, NSN: 6505-01-480-2501, Purchase Request: 7017127610) Approved Sources: - CAGE: 1DQP2, Part No: NDC63323-0237-10 - CAGE: 32655, Part No: NDC00143-9924-90, Company: HIKMA PHARMACEUTICALS USA INC. - CAGE: 6XJQ8, Part No: NDC44567-0707-25, Company: WG CRITICAL CARE, LLC